Brokers Issue Forecasts for Organigram Q4 Earnings

Organigram Holdings Inc. (TSE:OGIFree Report) – Equities researchers at Alliance Global Partners decreased their Q4 2024 earnings estimates for Organigram in a research report issued to clients and investors on Monday, December 9th. Alliance Global Partners analyst A. Grey now expects that the company will post earnings per share of ($0.03) for the quarter, down from their previous estimate of ($0.02). The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Alliance Global Partners also issued estimates for Organigram’s Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.01) EPS and FY2025 earnings at ($0.03) EPS.

Separately, Canaccord Genuity Group dropped their price target on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research report on Monday.

View Our Latest Report on Organigram

Organigram Trading Down 0.5 %

Shares of TSE OGI opened at C$2.16 on Wednesday. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.13. The stock’s 50 day moving average price is C$2.29 and its two-hundred day moving average price is C$2.31. Organigram has a 52-week low of C$1.61 and a 52-week high of C$3.95. The stock has a market capitalization of C$234.51 million, a P/E ratio of -0.86, a PEG ratio of 0.42 and a beta of 1.13.

Insiders Place Their Bets

In related news, Senior Officer Paolo De Luca sold 12,014 shares of the company’s stock in a transaction on Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total transaction of C$30,275.28. 31.32% of the stock is currently owned by corporate insiders.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Recommended Stories

Earnings History and Estimates for Organigram (TSE:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.